Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029463 (
osteosarcoma
)
16,637
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The components of the extracellular matrix (ECM) and their differential expression patterns play important roles in tissue formation. The deposition of latent TGF-beta binding proteins (LTBPs) to the ECM exhibit distinct distribution profiles. We have analyzed here the temporal and spatial ECM association of latent TGF-beta binding protein
LTBP-2
in cultured human embryonic lung fibroblasts. We found that
LTBP-2
was not assembled to the ECM until by confluency of cultures following the deposition of fibronectin (FN) and fibrillin-1. In 5-day-old cultures
LTBP-2
was rapidly secreted from cells and it subsequently associated with the ECM as shown by metabolic labeling and immunoprecipitation.
LTBP-2
colocalized transiently with fibronectin and failed to assemble to the ECM of FN deficient mouse fibroblasts. Analysis of different cultured human cell lines revealed partial colocalization of
LTBP-2
and fibrillin-1 in the ECM of fibroblasts, MG-63
osteosarcoma
cells and human vascular endothelial cells. Silencing of fibrillin-1 expression by lentiviral shRNAs profoundly disrupted the deposition of
LTBP-2
. Current results suggest that
LTBP-2
is not an element of the provisional ECM of fibroblasts but is more likely a component of more mature ECM and indicate that matrix association of
LTBP-2
depends on a pre-formed fibrillin-1 network.
...
PMID:Matrix association of latent TGF-beta binding protein-2 (LTBP-2) is dependent on fibrillin-1. 1968 Oct 46